Literature DB >> 24627036

Blood biomarkers for brain injury in concussed professional ice hockey players.

Pashtun Shahim, Yelverton Tegner, David H Wilson, Jeffrey Randall, Tobias Skillbäck, David Pazooki, Birgitta Kallberg, Kaj Blennow, Henrik Zetterberg.   

Abstract

IMPORTANCE: Lack of objective biomarkers for brain damage hampers acute diagnosis and clinical decision making about return to play after sports-related concussion.
OBJECTIVES: To determine whether sports-related concussion is associated with elevated levels of blood biochemical markers of injury to the central nervous system and to assess whether plasma levels of these biomarkers predict return to play in professional ice hockey players with sports-related concussion. DESIGN, SETTING, AND PARTICIPANTS: Multicenter prospective cohort study involving all 12 teams of the top professional ice hockey league in Sweden, the Swedish Hockey League. Two hundred eighty-eight professional ice hockey players from 12 teams contesting during the 2012-2013 season consented to participate. All players underwent clinical preseason baseline testing regarding concussion assessment measures. Forty-seven players from 2 of the 12 ice hockey teams underwent blood sampling prior to the start of the season. Thirty-five players had a concussion from September 13, 2012, to January 31, 2013; of these players, 28 underwent repeated blood sampling at 1, 12, 36, and 144 hours and when the players returned to play. MAIN OUTCOMES AND MEASURES: Total tau, S-100 calcium-binding protein B, and neuron-specific enolase concentrations in plasma and serum were measured.
RESULTS: Concussed players had increased levels of the axonal injury biomarker total tau(median, 10.0 pg/mL; range, 2.0-102 pg/mL) compared with preseason values (median, 4.5pg/mL; range, 0.06-22.7 pg/mL) (P < .001). The levels of the astroglial injury biomarker S-100 calcium-binding protein B were also increased in players with sports-related concussion(median, 0.075 μg/L; range, 0.037-0.24 μg/L) compared with preseason values (median,0.045 μg/L; range, 0.005-0.45 μg/L) (P < .001). The highest biomarker concentrations of total tau and S-100 calcium-binding protein B were measured immediately after a concussion, and they decreased during rehabilitation. No significant changes were detected in the levels of neuron-specific enolase from preseason values (median, 6.5 μg/L; range,3.45-18.0 μg/L) to postconcussion values (median, 6.1 μg/L; range, 3.6-12.8 μg/L) (P = .10). CONCLUSIONS AND RELEVANCE: Sports-related concussion in professional ice hockey players is associated with acute axonal and astroglial injury. This can be monitored using blood biomarkers, which may be developed into clinical tools to guide sport physicians in the medical counseling of athletes in return-to-play decisions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627036     DOI: 10.1001/jamaneurol.2014.367

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  118 in total

1.  Longitudinal assessment of white matter abnormalities following sports-related concussion.

Authors:  Timothy B Meier; Maurizio Bergamino; Patrick S F Bellgowan; T K Teague; Josef M Ling; Andreas Jeromin; Andrew R Mayer
Journal:  Hum Brain Mapp       Date:  2015-12-10       Impact factor: 5.038

2.  Levels of tau protein in plasma are associated with neurodegeneration and cognitive function in a population-based elderly cohort.

Authors:  Jeffrey L Dage; Alexandra M V Wennberg; David C Airey; Clinton E Hagen; David S Knopman; Mary M Machulda; Rosebud O Roberts; Clifford R Jack; Ronald C Petersen; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2016-07-18       Impact factor: 21.566

Review 3.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

4.  Concussion Biomarkers Assessed in Collegiate Student-Athletes (BASICS) I: Normative study.

Authors:  Breton M Asken; Russell M Bauer; Steven T DeKosky; Zachary M Houck; Charles C Moreno; Michael S Jaffee; Arthur G Weber; James R Clugston
Journal:  Neurology       Date:  2018-11-07       Impact factor: 9.910

5.  Circulating Brain-Derived Neurotrophic Factor Has Diagnostic and Prognostic Value in Traumatic Brain Injury.

Authors:  Frederick K Korley; Ramon Diaz-Arrastia; Alan H B Wu; John K Yue; Geoffrey T Manley; Haris I Sair; Jennifer Van Eyk; Allen D Everett; David O Okonkwo; Alex B Valadka; Wayne A Gordon; Andrew I R Maas; Pratik Mukherjee; Esther L Yuh; Hester F Lingsma; Ava M Puccio; David M Schnyer
Journal:  J Neurotrauma       Date:  2015-09-18       Impact factor: 5.269

Review 6.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

Review 7.  Blood-brain barrier imaging in human neuropathologies.

Authors:  Ronel Veksler; Ilan Shelef; Alon Friedman
Journal:  Arch Med Res       Date:  2014-11-29       Impact factor: 2.235

Review 8.  Emerging technologies to increase ligand binding assay sensitivity.

Authors:  Saloumeh K Fischer; Alison Joyce; Mark Spengler; Tong-Yuan Yang; Yao Zhuang; Marianne Scheel Fjording; Alvydas Mikulskis
Journal:  AAPS J       Date:  2014-10-18       Impact factor: 4.009

Review 9.  Expert consensus document: Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions.

Authors:  Aaron J Carman; Rennie Ferguson; Robert Cantu; R Dawn Comstock; Penny A Dacks; Steven T DeKosky; Sam Gandy; James Gilbert; Chad Gilliland; Gerard Gioia; Christopher Giza; Michael Greicius; Brian Hainline; Ronald L Hayes; James Hendrix; Barry Jordan; James Kovach; Rachel F Lane; Rebekah Mannix; Thomas Murray; Tad Seifert; Diana W Shineman; Eric Warren; Elisabeth Wilde; Huntington Willard; Howard M Fillit
Journal:  Nat Rev Neurol       Date:  2015-03-17       Impact factor: 42.937

10.  Diagnosis of traumatic brain injury using miRNA signatures in nanomagnetically isolated brain-derived extracellular vesicles.

Authors:  J Ko; M Hemphill; Z Yang; E Sewell; Y J Na; D K Sandsmark; M Haber; S A Fisher; E A Torre; K C Svane; A Omelchenko; B L Firestein; R Diaz-Arrastia; J Kim; D F Meaney; D Issadore
Journal:  Lab Chip       Date:  2018-10-25       Impact factor: 6.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.